Thomas Mark - Publications, H-index & Citations

Back

Thomas Mark

university of vermont

14H-index

61Paper Count

748Citation Count

Published Papers 9

Publication Date

Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial

LEUKEMIA

IF13.4

2024-09-25

OAAI

Thieblemont, Catherine; Karimi, Yasmin H.; Ghesquieres, Herve; Cheah, Chan Y.; Clausen, Michael Roost; Cunningham, David; Jurczak, Wojciech; Do, Young Rok; Gasiorowski, Robin; Lewis, David John; Kim, Tae Min; van der Poel, Marjolein; Poon, Michelle Limei; Feldman, Tatyana; Linton, Kim M.; Sureda, Anna; Hutchings, Martin; Dinh, Minh H.; Kilavuz, Nurgul; Soong, David; Mark, Thomas; Sacchi, Mariana; Phillips, Tycel; Lugtenburg, Pieternella J.

Save

Tralokinumab Provides Clinically Meaningful Responses at Week 16 in Adults with Moderate-to-Severe Atopic Dermatitis Who Do Not Achieve IGA 0/1

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

IF8.8

2023-10-07

OAAI

Simpson, Eric L.; Blauvelt, Andrew; Silverberg, Jonathan I.; Cork, Michael J.; Katoh, Norito; Mark, Thomas; Schneider, Shannon K. R.; Wollenberg, Andreas

Save

Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis

JAMA DERMATOLOGY

IF11

2023-10-01

OAAI

Merola, Joseph F.; Butler, Daniel C.; Mark, Thomas; Schneider, Shannon; Kim, Yestle; Abuabara, Katrina

Save

Effects of semaglutide on risk of cardiovascular events across a continuum of cardiovascular risk: combined post hoc analysis of the SUSTAIN and PIONEER trials

CARDIOVASCULAR DIABETOLOGY

IF10.6

2020-09-30

OAAI

Husain, Mansoor; Bain, Stephen C.; Holst, Anders Gaarsdal; Mark, Thomas; Rasmussen, Soren; Lingvay, Ildiko

Save

Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14

CARDIOVASCULAR DIABETOLOGY

IF10.6

2019-11-15

OAAI

Pratley, Richard E.; Husain, Mansoor; Lingvay, Ildiko; Pieber, Thomas R.; Mark, Thomas; Saevereid, Hans A.; Moller, Daniel Vega; Zinman, Bernard

Save

Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7)

DIABETES OBESITY & METABOLISM

IF5.7

2019-04-15

OAAI

Pratley, Richard E.; Emerson, Scott S.; Franek, Edward; Gilbert, Matthew P.; Marso, Steven P.; McGuire, Darren K.; Pieber, Thomas R.; Zinman, Bernard; Hansen, Charlotte T.; Hansen, Melissa V.; Mark, Thomas; Moses, Alan C.; Buse, John B.

Save

Cardiovascular (CV) Safety and Severe Hypoglycemia Benefit of Insulin Degludec vs. Insulin Glargine U100 in Older Patients (=65 Years) with Type 2 Diabetes (T2D)-Observations from DEVOTE

DIABETES

IF7.5

2018-07-01

PREAI

Pratley, Richard E.; Emerson, Scott S.; Franek, Edward; Gilbert, Matthew P.; Marso, Steven P.; Mcguire, Darren K.; Pieber, Thomas R.; Poulter, Neil R.; Hansen, Charlotte T.; Hansen, Melissa V.; Mark, Thomas; Moses, Alan C.; Zinman, Bernard

Save

Genomic applications in horse breeding

ANIMAL FRONTIERS

IF4.2

2016-01-01

OAAI

Stock, Kathrin F.; Jonsson, Lina; Ricard, Anne; Mark, Thomas

Save

Estimation of (co)variances for genomic regions of flexible sizes: application to complex infectious udder diseases in dairy cattle

GENETICS SELECTION EVOLUTION

IF3.1

2012-05-28

OAAI

Sorensen, Lars P.; Janss, Luc; Madsen, Per; Mark, Thomas; Lund, Mogens S.

Save

Research Directions